Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Management of paediatric immune thrombocytopaenia in a South African centre from 1991-2011

Three hundred and seventeen patients meeting the diagnostic criteria for immune thrombocytopenia presented to Red Cross War Memorial Children's Hospital between 1991 and 2011. We retrospectively reviewed these patients in order to describe patient demography, the natural history of the disease, and...

Full description

Saved in:
Bibliographic Details
Main Author: Akhalwaya, Shehnaaz
Other Authors: Davidson, Alan
Format: Thesis
Language:English
Published: Department of Paediatrics and Child Health 2017
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867614458655801344
access_status_str Open Access
author Akhalwaya, Shehnaaz
author2 Davidson, Alan
author_browse Akhalwaya, Shehnaaz
Davidson, Alan
author_facet Davidson, Alan
Akhalwaya, Shehnaaz
author_sort Akhalwaya, Shehnaaz
collection Thesis
description Three hundred and seventeen patients meeting the diagnostic criteria for immune thrombocytopenia presented to Red Cross War Memorial Children's Hospital between 1991 and 2011. We retrospectively reviewed these patients in order to describe patient demography, the natural history of the disease, and different approaches to diagnosis and management. There were 162 males and 155 female patients. The median age of onset was 3.48 years old (IQR 1.66-6.36). In the 4 weeks preceding presentation, 98 (31%) patients had a viral illness. The median presenting platelet count was 7 x 109/L (IQR 3-14.5). Petechiae were the most common clinical sign at presentation (58%; 184/317). None of the patients presented with intracranial haemorrhages. The majority of patients in the study were admitted (234/317; 74%) with a median stay of 4 days (IQR 0-6). Bone marrow aspirates (BMA) were performed in 188 patients (59%). There was a reduction in BMA from 1991-2000 to 2001-2011 (p<0.001). There was an increase in the percentage of patients treated from 1991-2000 (77/170; 44%) to 2001-2011 (99/147, 67% p< 0.001). Resolution occurred in 75% of patients with a median time to resolution of 31 days (IQR 11-73 days). When we analysed the "survival estimate" from the 2 decades, despite differing rates of BMA, treatment rates and regimens, there was no statistical difference in resolution.
format Thesis
id oai:open.uct.ac.za:11427/22793
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:52:22.169Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2017
publishDateRange 2017
publishDateSort 2017
publisher Department of Paediatrics and Child Health
publisherStr Department of Paediatrics and Child Health
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/22793 Management of paediatric immune thrombocytopaenia in a South African centre from 1991-2011 Akhalwaya, Shehnaaz Davidson, Alan Paediatrics Three hundred and seventeen patients meeting the diagnostic criteria for immune thrombocytopenia presented to Red Cross War Memorial Children's Hospital between 1991 and 2011. We retrospectively reviewed these patients in order to describe patient demography, the natural history of the disease, and different approaches to diagnosis and management. There were 162 males and 155 female patients. The median age of onset was 3.48 years old (IQR 1.66-6.36). In the 4 weeks preceding presentation, 98 (31%) patients had a viral illness. The median presenting platelet count was 7 x 109/L (IQR 3-14.5). Petechiae were the most common clinical sign at presentation (58%; 184/317). None of the patients presented with intracranial haemorrhages. The majority of patients in the study were admitted (234/317; 74%) with a median stay of 4 days (IQR 0-6). Bone marrow aspirates (BMA) were performed in 188 patients (59%). There was a reduction in BMA from 1991-2000 to 2001-2011 (p<0.001). There was an increase in the percentage of patients treated from 1991-2000 (77/170; 44%) to 2001-2011 (99/147, 67% p< 0.001). Resolution occurred in 75% of patients with a median time to resolution of 31 days (IQR 11-73 days). When we analysed the "survival estimate" from the 2 decades, despite differing rates of BMA, treatment rates and regimens, there was no statistical difference in resolution. 2017-01-18T13:09:56Z 2017-01-18T13:09:56Z 2016 Master Thesis Masters MMed http://hdl.handle.net/11427/22793 eng application/pdf Department of Paediatrics and Child Health Faculty of Health Sciences University of Cape Town
spellingShingle Paediatrics
Akhalwaya, Shehnaaz
Management of paediatric immune thrombocytopaenia in a South African centre from 1991-2011
thesis_degree_str Master's
title Management of paediatric immune thrombocytopaenia in a South African centre from 1991-2011
title_full Management of paediatric immune thrombocytopaenia in a South African centre from 1991-2011
title_fullStr Management of paediatric immune thrombocytopaenia in a South African centre from 1991-2011
title_full_unstemmed Management of paediatric immune thrombocytopaenia in a South African centre from 1991-2011
title_short Management of paediatric immune thrombocytopaenia in a South African centre from 1991-2011
title_sort management of paediatric immune thrombocytopaenia in a south african centre from 1991 2011
topic Paediatrics
url http://hdl.handle.net/11427/22793
work_keys_str_mv AT akhalwayashehnaaz managementofpaediatricimmunethrombocytopaeniainasouthafricancentrefrom19912011